Advent Pharma (DHA:ADVENT) Ending Cash Position: BDT0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:ADVENT Advent Pharma Ltd DHA:ADVENT
32 GF Score
Price BDT15.20
View Full Analysis

What is Advent Pharma Ending Cash Position?

Advent Pharma DHA:ADVENT -1.30% 32 Ending Cash Position is BDT0.00 Mil as of . 20. GuruFocus rates DHA:ADVENT with a GF Score™ of 32/100.

Advent Pharma's Ending Cash Position for the quarter that ended in . 20 was BDT0.00 Mil.

Advent Pharma Ending Cash Position Related Terms

Advent Pharma Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Advent Pharma's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advent Pharma Ending Cash Position Chart

Advent Pharma Annual Data
Trend
Ending Cash Position

Advent Pharma Semi-Annual Data
Ending Cash Position
DHA:ADVENT
32GF Score
Advent Pharma Ltd DHA:ADVENT
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advent Pharma Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Advent Pharma's Ending Cash Position for the fiscal year that ended in . 20 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=+
=0.00

Advent Pharma's Ending Cash Position for the quarter that ended in . 20 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=+
=0.00

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of BDT0.00 Mil mean?
Advent Pharma (DHA:ADVENT) has a Ending Cash Position of BDT0.00 Mil as of . 20. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Advent Pharma and its competitors.
Is Advent Pharma's Ending Cash Position too high?
Advent Pharma's current Ending Cash Position is BDT0.00 Mil. Overall, Advent Pharma has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Advent Pharma's Ending Cash Position compare to ?
Advent Pharma's Ending Cash Position of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Advent Pharma and its competitors. Advent Pharma's current Ending Cash Position is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advent Pharma stock overvalued right now?
Advent Pharma (DHA:ADVENT) has a current Ending Cash Position of BDT0.00 Mil. The current Ending Cash Position is BDT0.00 Mil. Advent Pharma's overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Advent Pharma (DHA:ADVENT), the current Ending Cash Position is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advent Pharma Business Description

Comparable Companies
Address Kakrail V.I.P. Road, Level no. 10, 80, Rupayan Karim Tower, Kakrail, Ramna, Dhaka, BGD, 1000
Advent Pharma Ltd is a Bangladesh-based company engaged in producing animal healthcare drugs and nutritional supplements for livestock.
32GF Score

Get the complete analysis for DHA:ADVENT

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT15.20
Price